Immunopathogenesis of recurrent vulvovaginal candidiasis

Clinical Microbiology Reviews

Volumn 9, Issue 3, 1996, Pages 335-348

  Fidel Jr , Paul L ^a,b   Sobel, Jack D ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANDIDA ALBICANS; CELLULAR IMMUNITY; CLINICAL FEATURE; HOST RESISTANCE; HUMAN; IMMUNE SYSTEM; IMMUNOPATHOGENESIS; NONHUMAN; RECURRENT INFECTION; REVIEW; VAGINA CANDIDIASIS; VAGINA MUCOSA; VAGINITIS;

ANIMALIA; CANDIDA ALBICANS;

EID: 0347809620     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/cmr.9.3.335-348.1996     Document Type: Review

References (117)

1. Anonymous. 1995. Mucosal immunology update, vol. 3, p. 1-15. Official publication of the Society for Mucosal Immunology. Raven Press, New York.
2. Balish, E., H. Filutowicz, and T. D. Oberley. 1990. Correlates of cell-mediated immunity in Candida albicans-colonized gnotobiotic mice. Infect. Immun. 58:107-113.
3. Brenner, M. B., J. L. Strominger, and M. S. Krangel. 1988. The gamma delta T cell receptor. Adv. Immunol. 43:133-192.
4. Cain, T. K., and R. G. Rank. 1995. Local Th1-like responses are induced by intravaginal infection of mice with the mouse pneumonitis biovar of Chlamydia trachomatis. Infect. Immun. 63:1784-1789.
5. Cantorna, M. T., and E. Balish. 1990. Mucosal and systemic candidiasis in congenitally immunodeficient mice. Infect. Immun. 58:1093-1100.
6. Cantorna, M. T., D. Mook, and E. Balish. 1990. Resistance of congenitally immunodeficient gnotobiotic mice to vaginal candidiasis. Infect. Immun. 58:3813-3815.
7. Carlsten, H., R. Holmdahl, and A. Tarkowski. 1991. Analysis of the genetic encoding of oestradiol suppression of delayed-type hypersensitivity in (NZB x NZW) F1 mice. Immunology 73:186-190.
8. Cassone, A., F. DeBernardis, F. Mondello, T. Ceddia, and L. Agatensi. 1987. Evidence for a correlation between proteinase secretion and vulvo-vaginal candidosis. J. Infect. Dis. 156:777-783.
9. Clerici, M., and G. M. Shearer. 1993. A TH1-TH2 switch is a critical step in the etiology of HIV infection. Immunol. Today 14:107-111.
10. Clift, R. A. 1984. Candidiasis in the transplant patient. Am. J. Med. 77(Suppl. 4D):34-38.
11. Dabrowa, N., and D. H. Howard. 1984. Heat shock and heat stroke proteins observed during germination of the blastoconidia of Candida albicans. Infect. Immun. 44:537-539.
12. Daynes, R.A., and B.A. Araneo. 1989. Contrasting effects of glucocorticoids on the capacity of T cells to produce the growth factors interleukin 2 and interleukin 4. Eur. J. Immunol. 19:2319-2325.
13. Daynes, R. A., D. J. Dadley, and B. A. Araneo. 1990. Regulation of murine lymphokine production in vivo. Eur. J. Immunol. 20:793-802.
14. De Bernardis, F., L. Agatensi, I. K. Ross, G. W. Emerson, R. Lorenzini, P. A. Sullivan, and A. Cassone. 1990. Evidence for a role for secreted aspartate proteinase of Candida albicans in vulvovaginal candidiasis. J. Infect. Dis. 161:1276-1283.
15. De Bernardis, F., A. Cassone, J. Sturtrvant, and R. Calderone. 1995. Expression of Candida albicans SAP1 and SAP2 in experimental vaginitis. Infect Immun. 63:1887-1892.
16. DeBernardis, F., A. Molinari, M. Boccanera, A. Stringaro, R. Robert, J.M. Senet, G. Arancia, and A. Cassone. 1994. Modulation of cell surface-associated mannoprotein antigen expression in experimental Candidal vaginitis. Infect. Immun. 62:509-519.
17. Ehrensaft, D. V., R. B. Epstiea, S. Sarpel, and B. R. Andersen. 1979. Disseminated candidias in leukopenic dogs. Proc. Soc. Exp. Biol. Med. 160:6-10.
18. Elin, R. J., J. B. Edelin, and S. M. Wolff. 1974. Infection and immunoglobulin concentrations in Chediak-Higashi mice. Infect. Immun. 10:88-91.
19. Ferrante, A., and Y. H. Thong. 1979. Requirement of heat-labile opsonins for maximal phagocytosis of Candida albicans. Sabouraudia 17:293-297.
20. Fidel, P. L., Jr., M. E. Lynch, D. H. Conaway, L. Tait, and J. D. Sobel. 1995. Mice immunized by primary vaginal Candida albicans infection develop acquired vaginal mucosal immunity. Infect. Immun. 63:547-553.
21. Fidel, P. L., Jr., M. E. Lynch, V. Redondo-Lopez, J. D. Sobel, and R. Robinson. 1993. Systemic cell-mediated immune reactivity in women with recurrent vulvovaginal candidiasis (RVVC). J. Infect. Dis. 168:1458-1465.
22. Fidel, P. L., Jr., M. E. Lynch, and J. D. Sobel. 1993. Candida-specific Th1-type responsiveness in mice with experimental vaginal candidiasis. Infect. Immun. 61:4202-4207.
23. Fidel, P. L., Jr., M. E. Lynch, and J. D. Sobel. 1993. Candida-specific cell-mediated immunity is demonstrable in mice with experimental vaginal candidiasis. Infect. Immun. 61:1990-1995.
24. Fidel, P. L., Jr., M. E. Lynch, and J. D. Sobel. 1994. Effects of preinduced Candida-specific systemic cell-mediated immunity on experimental vaginal candidiasis. Infect. Immun. 62:1032-1038.
25. Fidel, P. L., Jr., M. E. Lynch, and J. D. Sobel. 1995. Circulating CD4 and CD8 T cells have little impact on host defense against experimental vaginal candidiasis. Infect. Immun. 63:2403-2408.
26. Fidel, P. L., Jr., N. A. Wolf, and M. A. Kukuruga. T lymphocytes in the murine vaginal mucosa are phenotypically distinct from those in the periphery. Infect Immun., in press.
27. Florentino, D. F., A. Zlotnik, P. Vieira, T. R. Mosmann, M. Howard, K. W. Moore, and A. O'Garra. 1991. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J. Immunol. 146:3444-3451.
28. Fischer, A., J. J. Ballet, and C. Griscelli. 1978. Specific inhibition of m vitro Candida-induced lymphocyte proliferation by polysaccharide antigens present in serum of patients with chronic mucocutaneous candidiasis. J. Clin. Invest. 62:1005-1013.
29. Fleury, F. J. 1981. Adult vaginitis. Clin. Obstet. Gynecol. 24:407-438.
30. Fong, I. W., R. M. Bannatyne, and P. Wong. 1993. Lack of in vitro resistance of Candida albicans to ketoconazole, itraconazole and clotrimazole in women treated for recurrent vaginal candidiasis. Genitourin. Med. 69:44-46.
31. Fong, I. W., P. McCleary, and S. Read. 1992. Cellular immunity of patients with recurrent or refractory vulvovaginal moniliasis. Am. J. Obstet. Gynecol. 166:887-890.
32. Frazier-Jessen, M. R., and E. J. Kovacs. 1995. Estrogen modulation of JE/monocyte chemoattractant protein-1 mRNA expression in murine macrophages. J. Immunol. 154:1838-1845.
33. Gajewski, T. F., J. Joyce, and F. W. Fitch. 1989. Antiproliferative effect of IFN-gamma in immune regulation. III. Differential selection of Th1 and Th2 murine helper T lymphocyte clones using recombinant IL-2 and recombinant IFN-gamma. J. Immunol. 143:15-22.
34. Hobbs, J. R., D. Briden, F. Davidson, M. Kahan, and J. K. Oates. 1977. Immunological aspects of Candidal vaginitis. Proc. R. Soc. Med. 70:11-14.
35. Hocini, H., A. Barra, L. Belec, S. Iscaki, J. L. Preud'Homme, J. Pillot, and J. P. Bouvet. 1995. Systemic and secretory humoral immunity in the normal human vaginal tract. Scand. J. Immunol. 42:269-274.
36. Holm, H. W., and R. M. Marwin. 1967. Effects of surface active agents on the susceptibility of Swiss mice to Candida albicans. Mycopathol. Mycol. Appl. 33:186-192.
37. Hostager, B. S., D. R. DeSilva, M. K. Jenkins, and R. D. Nelson. Prostaglandin E2 facilitates anergy induction in murine T lymphocyte clones. Submitted for publication.
38. Hurley, R. 1977. Trends in candidal vaginitis. Proc. R. Soc. Med. 70(Suppl. 4):1-8.
39. Hurley, R. 1981. Recurrent Candida infection. Clin. Obstet. Gynecol. 8:209-213.
40. Hurley, R., and J. De Louvois. 1979. Candida vaginitis. Postgrad. Med. J. 55:645-647.
41. Igietseme, J. U., and R. G. Rank. 1991. Susceptibility to reinfection after a primary chlamydial genital infection is associated with a decrease of antigen-specific T celle in the genital tract. Infect Immun. 59:1346-1351.
42. Itohara, S., A. G. Farr, J. J. Lafaille, M. Bonneville, Y. Takagaki, W. Haas, and S. Tonegawa. 1990. Homing of a gamma/delta thymoeyte subset with homogenous T-cell receptors to mucosal epithelia, Nature (London) 343: 754-757.
43. Kagaya, K., and T. Fukazawa. 1981. Murine defense mechanism against Candida albicans infection. II. Opsonization, phagocytosis and intracellular killing of Candida albicans. Microbiol. Immunol. 25;807-818.
44. Kalo-Klein, A., and S. S. Witkin. 1990. Prostaglandin E2 enhances and gamma interferon inhibits germ tube formation in Candida albicans. Infect. Immun. 58:260-262.
45. Kalo-Klein, A., and S. S. Witkin. 1991. Regulation of the immune response to Candida albicans by monocytes and progesterone. Am. J. Obstet. Gynecol. 164:1351-1354.
46. Kaufmann, S. H. E. 1990. Heat shock proteins and the immune response. Immunol. Today 11:129-136.
47. Kent, H. L. 1991. Epidemiology of vaginitis. Am. J. Obstet. Gynecol. 165: 1168-1175.
48. Kinsman, O. S., and A. E. Collard. 1986. Hormonal factors in vaginal candidiasis in rats. Infect. Immun. 53:498-504.
49. Kirkpatrick, C. H. 1989. Chronic mucocutaneous candidiasis. Eur. J. Clin. Microbiol. Infect. Dis. 8:448-456.
50. Kirkpatrick, C. H., R. R. Rich, and J. E. Bennett. 1971. Chronic mucocutaneous candidiasas: model-building in cellular immunity. Ann. Intern. Med. 74:955-978.
51. Klein, R. S., C. A. Harris, C. B. Small, B. Moll, M. Lesser, and G. H. Friedland. 1984. Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunologiodeficiency syndrome. N. Engl. J. Med. 311:354-358.
52. Klink, M., B. Rozalaska, and W. Rudnicka. 1993. Weakness of cellular response to Listeria antigens in pregnant mice. Med. Dosw. Mikrobiol. 45:51-54. (In Polish.)
53. Knight, L., and J. Eletcher. 1971. Growth of Candida albicans in saliva: stimulation by glucose associated with antibiotics, corticosteroids and diabetes mellitus. J. Infect. Dis. 123:371-377.
54. Liljemark, W. F., and R. J. Gibbons. 1973. Suppression of Candida albicans by human oral streptococci in gnotobiotic mice. Infect. Immun. 8:846-849.
55. Lynch, M. E., P. L. Fidel, Jr., and J. D. Sobel. 1994. Characterization of a C. albicans germ tube inhibitor in culture supernatants from stimulated peripheral blood mononuclear cells, abstr. F-22, p. 592. In Abstracts of the 94th General Meeting of the American Society for Microbiology 1994. American Society for Microbiology, Washington, D.C.
56. Lynch, M.E., J. D. Sobel, and P. L. Fidel, Jr. 1996. The role of antifungal drug resistance in the pathogenesis of recurrent vulvovaginal candidiasis (RVVC). J. Med. Vet. Mycol., in press.
57. Macher, A. M. 1988. The pathology of AIDS. Public Health Rep. 103:246-250.
58. Maggi, E., M. Mazzetti, A. Ravina, F. Annunziato, M. De Carli, M. P. Piccinni, R. Manetti, M. Carbonari, A. M. Pesce, G. Del Prefe, and S. Romagnani. 1994. Ability of HIV to promote a Th1 to Th0 shift and to replicate preferentially in Th2 and Th0 cells. Science 265:244-248.
59. Mathur, S., G. Virella, J. Koistinen, E. O. Horger, T. A. Mahvi, and H. H. Fudenberg. 1977. Humoral immunity in vaginal candidiasis. Infect. Immun. 15:287-294.
60. Matthews, R., and J. Burnie. 1992. The role of hsp90 in fungal infection. Immunol. Today 13:345-348.
61. Matthews, R. C., J. P. Burnie, D. Howat, T. Rowland, and F. Walton. 1991. Autoantibody to heat-shock protein 90 can mediate protection against systemic candidosis. Immunology 74:20-24.
62. Matthews, R. C., J. P. Burnie, and S. Tabaqchali. 1984. Immunoblot analysis of the serological response in systemic candidosis. Lancet ii:1415-1418.
63. Matthews, R. C., J. P. Burnie, and S. Tabaqchali. 1987. Isolation of immunodominant antigens from sera of patients with systemic candidiasis and characterization of serological response to Candida albicans. J. Clin. Microbiol. 25:230-237.
64. Mazumder, D. N., N. Ghose, J. Mirta, G. Dutta, and A. Santra. 1990. Immunological status of women with prolonged oral contraceptives and occurrence of giardiasis. J. Indian Med. Assoc. 88:129-131.
65. Morris, H., M. Emms, T. Visser, and A. Timme. 1986. Lymphoid tissue of the normal fallopian tube - a form of mucosal-associated lyrnphoid tissue (MALT). Int. J. Gynecol. Pathol. 5:11-22.
66. Morton, R. S., and S. Rashid. 1977. Candidal vaginitis: natural history, predisposing factors and prevention. Proc. R. Soc. Med. 70(Suppl. 4):3-12.
67. Mosman, T. R., and R. L. Coffman. 1989. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145-173.
68. Nandi, D., and J. P. Allison. 1991. Phenotypic analysis and gamma/delta-T cell receptor repertoire of murine T cells associated with the vaginal epithelium. J. Immunol 147:1773-1778.
69. Nohmi, T., S. Abe, K. Dobashi, S. Tansho, and H. Yamaguchi. 1995. Suppression of anti-Candida activity of murine neutrophils by progesterone in vitro: a possible mechanism in pregnant women's vulnerability to vaginal candidiasis. Microbiol. Immunol. 39:405-409.
70. Odds, F. C. 1988. Chronic mucocutaneous candidosis, p. 144-152. In F. C. Odds (ed.), Candida and candidosis. Univeisity Park Press, Baltimore.
71. Parr, M. B., L. Kepple, and E. L. Parr. 1991. Antigen recognition in the female reproductive tract. II. Endocytosis of horseradish peroxidase by Jangerhans cells in murine vaginal epithelium. Biol. Reprod. 45:261-265.
72. Parr, M.B., L. Kepple, and E. L. Parr. 1991. Langerhans cells phagocytose vaginal epithelial cells undergoing apoptosis during the murine estrons cycle. Biol. Reprod. 45:252-260.
73. Parr, M. B., and E. L. Parr. 1990. Antigen recognition in the female reproductive tract I. Uptake of intraluminal protein tracers in the mouse vagina. J. Reprod. Immunol. 17:101-114.
74. Parr, M. B., and E. L. Parr. 1991. Langerhans cells and T lymphocyte subsets in the murine vagina and cervix. Biol. Reprod. 44:491-498.
75. Parr, M. B., and E. L. Parr. 1994. Mucosal immunity in the female and male reproductive tracts, p. 677-689. In P. L. Ogra, J. J. Mestecky. and M. E. Lamm (ed.), Handbook of mucosal immunity. Academic Press, Inc., San Diego, Calif.
76. Paterson, P. Y., R. Semo, G. Blumenschein, and J. Swelstad. 1971. Mucocutaneous candidiasis, anergy and a plasma inhibitor of cellular immunity: reversal after amphotericin B therapy. Clin. Exp. Immunol. 9:595-602.
77. Polonelli, L., F. De Bernardis, S. Conti, M. Boccanera, M. Gerloni, G. Morace, W. Magliani, C. Chezzi, and A. Cassone. 1994. Idiotypic intravaginal vaccination to protect against candidal vaginitis by secretory, yeast killer toxin-like anti-idiotypic antibodies. J. Immunol. 152:3175-3182.
78. Powell, B. L., and D. L Dratz. 1983. Estrogen receptor in Candida albicans: a possible explanation for hormonal influences in vaginal candidiasis, abstr. 751, p. 222. In Program and Abstracts of the 23rd Annual Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
79. Puccetti, P., L. Romani, and F. Bistoni. 1995. A Th1-Th2-like switch in candidiasis: new perspectives for therapy. Trends Microbiol. 3:237-240.
80. Regulez, P., J. F. Garcia Fernandez, M. D. Moragnes, J. Schneider, G. Quindos, and J. Ponton. 1994. Detection of anti-Candida albicans IgE antibodies in vaginal washes from patients with acute vulvovaginal candidiasis. Gynecol Obstet Invest 37:110-114.
81. Rigg, D., M. M. Miller, and W. J. Metzger. 1990. Recurrent allergic vulvovaginitis: treatment with Candida albicans allergen immunotherapy. Am. J. Obstet. Gynecol. 162:332-336.
82. Rogers, T. J., and E. Balish. 1980. Immunity to Candida albicans. Microbiol. Rev. 44:660-682.
83. Romani, L., A. Mencacci, E. Cenci, R. Spaccapelo, P. Mosci, P. Puccetti, and F. Bistoni. 1993. CD+ subset expression in murine candidiasis. J. Immunol. 150:925-931.
84. Romani, L., S. Mocci, C. Bietta, L. Lanfaloni, P. Puccetti, and F. Bistoni. 1991. Th1 and Th2 cytokise secretion patterns in murine candidiasis: association of Th1 responses with acquired resistance. Infect. Immun. 59: 4647-4654.
85. Rosedale, N., and M. B. Browne. 1979. Hyposensitisation in the management of recurring vaginal candidiasis. Ann. Allergy 43:250-253.
86. Ross, I. K., F. DeBernardis, G. W. Emerson, A. Cassone, and P. A. Sullivan. 1990. The secreted aspartate proteinase of Candida albicans: physiology of secretion and virulence of a proteinase-deficient mutant J. Gen. Microbiol. 136:687-694.
87. Ryley, J. F., and S. McGregor. 1986. Quantitation of vaginal Candida albicans infections in rodents. J. Med. Vet Mycol. 24:455-460.
88. Schroppel, K., M. Rotman, R. Galask, K. Mac, and D. R. Soll. 1994. Evolution and replacement of Candida albicans strains during recurrent vaginitis demonstrated by DNA fingerprinting. J. Clin. Microbiol. 32:2646-2654.
89. Schumacher, G. F. B. 1980. Humoral immune factors in the female reproductive tract and their changes during the cycle, p. 93-141. In D. Dinsda and G. Schumacher (ed.). Immunological aspects of infertility and fertility control. Elsevier/North-Holland Publishing Co., New York.
90. Sobel, J. D. 1988. Pathogenesis and epidemiology of vulvovaginal candidiasis. Ann. N. Y. Acad. Sci. 544:547-557.
91. Sobel, J. D. 1990. Vaginal infections in adult women. Sex. Transm. Dis. 74:1573-1601.
92. Sobel, J. D. 1996. Candida vaginitis. In W. Ledger and J. Witkin (ed.), Vulvovaginal disease, in press. The W. B. Saunders Co., Philadelphia.
93. Sobel, J. D., G. Muller, and H. R. Buckley. 1984. Critical role of germ tube formation in the pathogenesis of Candidal vaginitis. Infect Immun. 44:576-580.
94. Sobel, J. D., G. Muller, and J. F. McCormick. 1985. Experimental chronic vaginal candidosis in rats. Sabouraudia 23:199-206.
95. Sobel, J. D., P. G. Myer, D. Kaye, and M. E. Levinson. 1981. Candida albicans adherence to vaginal epithelial cells. J. Infect. Dis. 143:76-82.
96. Soll, D. R. 1988. High frequency switching in Candida albicans and its relations to vaginal candidiasis. Am. J. Obstet. Gynecol. 158:997-1001.
97. Soll, D. R. 1992. High-frequency switching in Candida albicans. Clin. Microbiol. Rev. 5:183-203.
98. Soll, D. R., R. Galask, S. Isley, et al. 1989. Switching of Candida albicans during successive episodes of recurrent vaginitis. J. Clin. Microbiol. 27:681-690.
99. Styrt, B., and B. Sugarman. 1991. Estrogens and infection. Rev. Infect. Dis. 13:1139-1150.
100. Syverson, R. A., H. Backley, J. Gibian, and J. M. Ryan, Jr. 1979. Cellular and humoral immune status in women with chronic Candida vaginitis. Am. J. Obstet. Gynecol. 134:624-627.
101. Thapar, M. A., E. I. Parr, J. J. Bozzola, and M. B. Parr. 1991. Secretory immune responses in the mouse vagina after parenteral or intravaginal immunization with an immunostimulating complex (ISCOM). Vaccine 9:129-133.
102. Thapar, M. A., E. L. Parr, and M. B. Parr. 1990. Secretory immune responses in mouse vaginal fluid after pelvic, parenteral or vaginal immunization. Immunology 70:121-125.
103. Trumbore, D. J., and J. D. Sobel. 1986. Recurrent vulvovaginal candidiasis: vaginal epithelial cell susceptibility to Candida albicans adherence. Obstet. Gynecol. 67:810-814.
104. Uehling, D. T., L. J. James, W. J. Hopkins, and E. Balish. 1991. Immunization against urinary tract infection with a multi-valent vaginal vaccine. J. Urol. 146:223-226.
105. Vazquez, J. A., J. D. Sobel, R. Demitriou, J. Vaishampayan, M. Lynch, and M. J. Zervos. 1994. Karyotyping of Candida albicans isolates obtained longitudinally in women with recurrent vulvovaginal candidiasis. J. Infect. Dis. 170:1566-1569.
106. Wira, C. R., and R. H. Prabhala. 1993. The female reproductive tract is an inductive site for immune responses: effect of oestradiol and antigen on antibody and secretory component levels in uterine and cervico-vaginal secretions following various routes of immunization, p. 271-293. In P. D. Griffin and P. M. Johnson (ed.), Scientific basis of fertility regulation: local immunity in reproductive tract tissues. Oxford University Press, New York.
107. Wira, C. R., J. Richardson, and R. Prabhala. 1994. Endocrine regulation of mucosal immunity: effect of ser hormones and cytokines on the afferent and efferent arms of the immune system in the female reproductive tract, p. 705-718. in P. L. Ogra, J. J. Mestecky, and M. E. Lamm (ed.), Handbook of mucosal immunity. Academic Press, Inc., San Diego, Calif.
108. Wira, C. R., and R. M. Rossoll. 1995. Antigen-presenting cells in the female reproductive tract: influence of sex hormones on antigen presentation in the vagina. Immunology 84:505-508.
109. Wira, C. R., and J. E. Stern. 1992. Endocrine regulation of the mucosal immune system in the female reproductive tract. Control of IgA, IgG, and secretory component during the reproductive cycle, at implantation, and throughout pregnancy, p. 343-367. In J. R. Pasqualini and R. Scholler (ed.), Hormones and fetal pathophysiology. Marcel Dekker. Inc., New York.
110. Witkin, S. S. 1991. Immunologic factors influencing susceptibility to recurrent candidal vaginitis. Clin. Obstet. Gynecol. 34:662-668.
111. Witkin, S. S., J. Hirsch, and W. J. Ledger. 1986. A macrophage defect to women with recurrent Candida vaginitis and its reversal in vitro by prostaglandin inhibitors. Am. J. Obstet. Gynecol. 155:790-795.
112. Witkin, S. S., J. Jeremias, and W. J. Ledger. 1988. A localized vaginal allergic response in women with recurrent vaginitis. J. Allergy Clin. Immunol. 81:412-416.
113. Witkin, S. S., J. Jeremias, and W. J. Ledger. 1989. Vaginal eosinophils and IgE antibodies to Candida albicans in women with recurrent vaginitis. J. Med. Vet. Mycol. 27:57-58.
114. Witkin, S. S., A. Kalo-Klein, L. Galland, M. Teich, and W. J. Ledger. 1991. Effect of Candida albicans plus histamine on prostaglandin E2 production by peripheral blood mononuclear cells from healthy women and women with recurrent candidal vaginitis. J. Infect. Dis. 164:396-399.
115. Witkin, S. S., I. R. Yu, and W. J. Ledger. 1983. Inhibition of Candida albicans-induced lymphocyte proliferation by lymphocytes and sera from women with recurrent vaginitis. Am. J. Obstet. Gynecol. 147:809-811.
116. Wu, H., and M. W. Russel. 1993. Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit. Infect. Immun. 61:314-322.
117. Yamamura, M., and H. Valdimarsson. 1977. Participation of C3 in intracellular Killing of Candida albicans. Scand. J. Immunol. 6:591-594.